Cargando…

Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)

INTRODUCTION: Numerous pathogenic mutations responsible for mitochondrial diseases have been identified in mitochondrial DNA (mtDNA)-encoded tRNA genes. In most cases, however, the detailed molecular pathomechanisms and cellular pathophysiology of these mtDNA mutations —how such genetic defects dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatakeyama, Hideyuki, Katayama, Ayako, Komaki, Hirofumi, Nishino, Ichizo, Goto, Yu-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546323/
https://www.ncbi.nlm.nih.gov/pubmed/26297375
http://dx.doi.org/10.1186/s40478-015-0227-x
_version_ 1782386903581982720
author Hatakeyama, Hideyuki
Katayama, Ayako
Komaki, Hirofumi
Nishino, Ichizo
Goto, Yu-ichi
author_facet Hatakeyama, Hideyuki
Katayama, Ayako
Komaki, Hirofumi
Nishino, Ichizo
Goto, Yu-ichi
author_sort Hatakeyama, Hideyuki
collection PubMed
description INTRODUCTION: Numerous pathogenic mutations responsible for mitochondrial diseases have been identified in mitochondrial DNA (mtDNA)-encoded tRNA genes. In most cases, however, the detailed molecular pathomechanisms and cellular pathophysiology of these mtDNA mutations —how such genetic defects determine the variation and the severity of clinical symptoms in affected individuals— remain unclear. To investigate the molecular pathomechanisms and to realize in vitro recapitulation of mitochondrial diseases, intracellular mutant mtDNA proportions must always be considered. RESULTS: We found a disease-causative mutation, m.5541C>T heteroplasmy in MT-TW gene, in a patient exhibiting mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with multiple organ involvement. We identified the intrinsic molecular pathomechanisms of m.5541C>T. This mutation firstly disturbed the translation machinery of mitochondrial tRNA(Trp) and induced mitochondrial respiratory dysfunction, followed by severely injured mitochondrial homeostasis. We also demonstrated cell-type-specific disease phenotypes using patient-derived induced pluripotent stem cells (iPSCs) carrying ~100 % mutant m.5541C>T. Significant loss of terminally differentiated iPSC-derived neurons, but not their stem/progenitor cells, was detected most likely due to serious mitochondrial dysfunction triggered by m.5541C>T; in contrast, m.5541C>T did not apparently affect skeletal muscle development. CONCLUSIONS: Our iPSC-based disease models would be widely available for understanding the "definite" genotype-phenotype relationship of affected tissues and organs in various mitochondrial diseases caused by heteroplasmic mtDNA mutations, as well as for further drug discovery applications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0227-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4546323
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45463232015-08-23 Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp) Hatakeyama, Hideyuki Katayama, Ayako Komaki, Hirofumi Nishino, Ichizo Goto, Yu-ichi Acta Neuropathol Commun Research INTRODUCTION: Numerous pathogenic mutations responsible for mitochondrial diseases have been identified in mitochondrial DNA (mtDNA)-encoded tRNA genes. In most cases, however, the detailed molecular pathomechanisms and cellular pathophysiology of these mtDNA mutations —how such genetic defects determine the variation and the severity of clinical symptoms in affected individuals— remain unclear. To investigate the molecular pathomechanisms and to realize in vitro recapitulation of mitochondrial diseases, intracellular mutant mtDNA proportions must always be considered. RESULTS: We found a disease-causative mutation, m.5541C>T heteroplasmy in MT-TW gene, in a patient exhibiting mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with multiple organ involvement. We identified the intrinsic molecular pathomechanisms of m.5541C>T. This mutation firstly disturbed the translation machinery of mitochondrial tRNA(Trp) and induced mitochondrial respiratory dysfunction, followed by severely injured mitochondrial homeostasis. We also demonstrated cell-type-specific disease phenotypes using patient-derived induced pluripotent stem cells (iPSCs) carrying ~100 % mutant m.5541C>T. Significant loss of terminally differentiated iPSC-derived neurons, but not their stem/progenitor cells, was detected most likely due to serious mitochondrial dysfunction triggered by m.5541C>T; in contrast, m.5541C>T did not apparently affect skeletal muscle development. CONCLUSIONS: Our iPSC-based disease models would be widely available for understanding the "definite" genotype-phenotype relationship of affected tissues and organs in various mitochondrial diseases caused by heteroplasmic mtDNA mutations, as well as for further drug discovery applications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0227-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-22 /pmc/articles/PMC4546323/ /pubmed/26297375 http://dx.doi.org/10.1186/s40478-015-0227-x Text en © Hatakeyama et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hatakeyama, Hideyuki
Katayama, Ayako
Komaki, Hirofumi
Nishino, Ichizo
Goto, Yu-ichi
Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)
title Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)
title_full Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)
title_fullStr Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)
title_full_unstemmed Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)
title_short Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)
title_sort molecular pathomechanisms and cell-type-specific disease phenotypes of melas caused by mutant mitochondrial trna(trp)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546323/
https://www.ncbi.nlm.nih.gov/pubmed/26297375
http://dx.doi.org/10.1186/s40478-015-0227-x
work_keys_str_mv AT hatakeyamahideyuki molecularpathomechanismsandcelltypespecificdiseasephenotypesofmelascausedbymutantmitochondrialtrnatrp
AT katayamaayako molecularpathomechanismsandcelltypespecificdiseasephenotypesofmelascausedbymutantmitochondrialtrnatrp
AT komakihirofumi molecularpathomechanismsandcelltypespecificdiseasephenotypesofmelascausedbymutantmitochondrialtrnatrp
AT nishinoichizo molecularpathomechanismsandcelltypespecificdiseasephenotypesofmelascausedbymutantmitochondrialtrnatrp
AT gotoyuichi molecularpathomechanismsandcelltypespecificdiseasephenotypesofmelascausedbymutantmitochondrialtrnatrp